DNA-repair-driven cell demise compels us to rethink most cancers therapies

Boon, N. J. et al. DNA harm induces p53-independent apoptosis by ribosome stalling. Science 384, 785–792 (2024).

CAS 

Google Scholar 

Ogawa, A. et al. SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis. Mol. Cell 85, 894–912.e810 (2025).

CAS 

Google Scholar 

Szmyd, R. et al. Homologous recombination promotes non-immunogenic mitotic cell demise upon DNA harm. Nat. Cell Biol. 27, 59–72 (2025).

CAS 

Google Scholar 

Scully, R., Panday, A., Elango, R. & Willis, N. A. DNA double-strand break repair-pathway selection in somatic mammalian cells. Nat. Rev. Mol. Cell Biol. 20, 698–714 (2019).

CAS 

Google Scholar 

Daum, J. R. et al. Cohesion fatigue induces chromatid separation in cells delayed at metaphase. Curr. Biol. 21, 1018–1024 (2011).

CAS 

Google Scholar 

Flynn, P. J., Koch, P. D. & Mitchison, T. J. Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells. Proc. Natl Acad. Sci. USA 118, e2103585118 (2021).

CAS 

Google Scholar 

Harding, S. M. et al. Mitotic development following DNA harm allows sample recognition inside micronuclei. Nature 548, 466–470 (2017).

CAS 

Google Scholar 

Ding, L. et al. PARP inhibition elicits STING-dependent antitumor immunity in Brca1-deficient ovarian most cancers. Cell Rep. 25, 2972–2980.e5 (2018).

CAS 

Google Scholar 

Oh, G. et al. POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma through cGAS/STING signaling. J. Clin. Invest. 133, e165934 (2023).

CAS 

Google Scholar 

Pantelidou, C. et al. PARP inhibitor efficacy relies on CD8+ T-cell recruitment through intratumoral STING pathway activation in BRCA-deficient fashions of triple-negative breast most cancers. Cancer Discov. 9, 722–737 (2019).

Google Scholar 

Heijink, A. M. et al. BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity. Nat. Commun. 10, 100 (2019).

Google Scholar 

Reisländer, T. et al. BRCA2 abrogation triggers innate immune responses potentiated by remedy with PARP inhibitors. Nat. Commun. 10, 3143 (2019).

Google Scholar 

Reed, A. D. et al. A single-cell atlas allows mapping of homeostatic mobile shifts within the grownup human breast. Nat. Genet. 56, 652–662 (2024).

CAS 

Google Scholar 

Tarsounas, M. & Sung, P. The antitumorigenic roles of BRCA1–BARD1 in DNA restore and replication. Nat. Rev. Mol. Cell Biol. 21, 284–299 (2020).

CAS 

Google Scholar 

Samstein, R. M. et al. Mutations in BRCA1 and BRCA2 differentially have an effect on the tumor microenvironment and response to checkpoint blockade immunotherapy. Nat. Cancer 1, 1188–1203 (2021).

Google Scholar